Transcriptional silencing disprupts two levels of arginine biosynthesis in glioblastoma multiforme: a novel targeted therapeutic strategy for high grade gliomas
Presented June 2012 at the British Neurooncology Society Conference
Nelofer Syed1; Kevin O’Neill1; Mark Hughes1; Christiana LoNigro2; Laura Lattanzio2; Peter Szlosarek3; Federico Roncaroli1; Timothy Crook1.
1’John Fulcher’ Molecular Neuro-oncology Laboratory, BTRC, Imperial College, London, UK, 2Laboratorio Oncologia Translazionale, Cuneo, Italy, 3 Queen Mary University of London, Institute of Cancer and CR-UK Clinical Centre, Barts and The London School of Medicine, London